• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用指圈(yubi-wakka)测试轻松监测慢性肝病患者的肌肉量下降。

Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.

机构信息

Gastroenterology Center, Ehime Prefectural Central Hospital, 83 Kasuga-cho, Matsuyama, Japan.

Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.

出版信息

J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):347-354. doi: 10.1002/jcsm.12392. Epub 2019 Feb 21.

DOI:10.1002/jcsm.12392
PMID:30793533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6463463/
Abstract

BACKGROUND

Muscle atrophy (MA) and muscle strength decline are important clinical features in chronic liver disease (CLD) patients. An easy to perform MA screening method without need for special equipment would be helpful. We evaluated the usefulness of the previously reported finger-circle test as screening for MA in CLD patients.

METHODS

We retrospectively enrolled 358 Japanese CLD outpatients (70.8 ± 10.2 years, male/female = 234/124) who had undergone a computed tomography examination from December 2017 to March 2018, of whom 137 had chronic hepatitis, 169 had liver cirrhosis Child-Pugh A, and 52 had liver cirrhosis Child-Pugh B/C. Bilateral psoas muscle area at the middle of the third lumber vertebra (L3) was evaluated with computed tomography findings, which was performed as a screening of hepatocellular carcinoma, using a previously reported parameter for MA [psoas index (PI): total psoas muscle area (cm )/height (m) ] [mean PI ± standard deviation (SD) of male patients: 6.50 ± 1.13 cm /m and those of female patients: 4.30 ± 0.90 cm /m ]. We then evaluated the correlation between MA and finger-circle test results in these patients.

RESULTS

The mean PI values for finger-circle test results Bigger, Just-fits, and Smaller were 5.64 ± 1.34, 5.00 ± 1.25, and 4.83 ± 1.46 cm /m , respectively, in male patients (P < 0.001) and 4.31 ± 1.06, 3.93 ± 0.97, and 3.42 ± 0.94 cm /m , respectively, in female patients (P = 0.001). We found that a finger-circle test result in male patients other than Bigger (Just-fits and Smaller) predicted a decline in psoas muscle area of L3 to PI 5.25 cm /m (sensitivity/specificity 0.619/0.667, area under the curve 0.654, 95% confidence interval 0.583-0.724), which was approximately mean minus 1 SD (5.37 cm /m ). On the other hand, a Smaller test result in female patients predicted a decline in psoas muscle area of L3 to PI 3.33 cm /m (sensitivity/specificity 0.740/0.583, area under the curve 0.698, 95% confidence interval 0.583-0.813), approximately mean minus 1 SD (3.40 cm /m ).

CONCLUSIONS

The finger-circle test is an easy to perform and effective screening method for predicting earlier stage of MA in CLD patients without the need for special equipment.

摘要

背景

肌肉萎缩(MA)和肌肉力量下降是慢性肝病(CLD)患者的重要临床特征。一种无需特殊设备即可进行的易于操作的 MA 筛查方法将很有帮助。我们评估了之前报道的手指圈试验作为 CLD 患者 MA 筛查的有用性。

方法

我们回顾性纳入了 2017 年 12 月至 2018 年 3 月期间接受过计算机断层扫描检查的 358 例日本 CLD 门诊患者(70.8±10.2 岁,男性/女性=234/124),其中 137 例患有慢性肝炎,169 例患有 Child-Pugh A 级肝硬化,52 例患有 Child-Pugh B/C 级肝硬化。使用先前报道的 MA 指标[腰大肌指数(PI):总腰大肌面积(cm)/身高(m)]评估第 3 腰椎(L3)中部的双侧腰大肌面积,计算机断层扫描检查是作为肝细胞癌的筛查方法进行的[男性患者的平均 PI±标准差(SD):6.50±1.13 cm/m,女性患者的平均 PI±SD:4.30±0.90 cm/m]。然后,我们评估了 MA 与这些患者手指圈试验结果之间的相关性。

结果

男性患者的手指圈试验结果大、刚好合适和小的平均 PI 值分别为 5.64±1.34、5.00±1.25 和 4.83±1.46 cm/m(P<0.001),女性患者的平均 PI 值分别为 4.31±1.06、3.93±0.97 和 3.42±0.94 cm/m(P=0.001)。我们发现,男性患者的手指圈试验结果不是大(刚好合适和小)可以预测腰大肌面积下降至 PI 5.25 cm/m(敏感性/特异性 0.619/0.667,曲线下面积 0.654,95%置信区间 0.583-0.724),这大约是平均值减去 1 SD(5.37 cm/m)。另一方面,女性患者的小手指圈试验结果可以预测腰大肌面积下降至 PI 3.33 cm/m(敏感性/特异性 0.740/0.583,曲线下面积 0.698,95%置信区间 0.583-0.813),这大约是平均值减去 1 SD(3.40 cm/m)。

结论

手指圈试验是一种无需特殊设备即可进行的简单有效的 MA 筛查方法,可预测 CLD 患者 MA 的早期阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/29af74f1133f/JCSM-10-347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/5bda53d456cf/JCSM-10-347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/1470e52a5d79/JCSM-10-347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/ae9bbdd95662/JCSM-10-347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/29af74f1133f/JCSM-10-347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/5bda53d456cf/JCSM-10-347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/1470e52a5d79/JCSM-10-347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/ae9bbdd95662/JCSM-10-347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda8/6463463/29af74f1133f/JCSM-10-347-g004.jpg

相似文献

1
Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.利用指圈(yubi-wakka)测试轻松监测慢性肝病患者的肌肉量下降。
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):347-354. doi: 10.1002/jcsm.12392. Epub 2019 Feb 21.
2
Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation.日本慢性肝病患者肌肉萎缩作为肌少症前期:计算机断层扫描对评估很有用。
J Gastroenterol. 2015 Dec;50(12):1206-13. doi: 10.1007/s00535-015-1068-x. Epub 2015 Mar 31.
3
Clinical impact of the finger-circle test in patients with liver diseases.指圈试验对肝病患者的临床影响。
Hepatol Res. 2021 May;51(5):603-613. doi: 10.1111/hepr.13639. Epub 2021 Apr 5.
4
Sensitivity and specificity of Yubi-wakka (finger-ring) screening method for sarcopenia among older Thai adults.尤比瓦卡(指环)筛查法用于老年泰国成年人肌少症的敏感性和特异性。
Geriatr Gerontol Int. 2024 Mar;24(3):263-268. doi: 10.1111/ggi.14787. Epub 2024 Jan 29.
5
Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease.日本慢性肝病患者的肌肉减少症及两种类型的肌肉减少症前期状态
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):940-7. doi: 10.1097/MEG.0000000000000661.
6
Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass.通过计算机断层扫描评估低肌肉量时 L3 椎体水平骨骼肌指数和腰大肌指数的截断值。
Clin Nutr. 2021 Jun;40(6):4360-4365. doi: 10.1016/j.clnu.2021.01.010. Epub 2021 Jan 16.
7
Psoas muscle area as a predictor of low muscle mass in Asian patients with compensated advanced chronic liver disease.腰大肌面积作为亚洲代偿期晚期慢性肝病患者低肌肉量的预测指标。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102379. doi: 10.1016/j.clinre.2024.102379. Epub 2024 May 23.
8
SARC-F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease.SARC-F联合一种简单工具用于评估慢性肝病门诊患者的肌肉异常情况。
Hepatol Res. 2020 Apr;50(4):502-511. doi: 10.1111/hepr.13469. Epub 2020 Jan 16.
9
Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.在肝硬化患者中,腰大肌指数对预测等待名单死亡率高的患者的表现不佳。
J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1053-1062. doi: 10.1002/jcsm.12349. Epub 2018 Sep 29.
10
A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.肝移植候选者的肌肉功能、质量和品质比较:肝移植研究功能评估结果
Transplantation. 2016 Aug;100(8):1692-8. doi: 10.1097/TP.0000000000001232.

引用本文的文献

1
Research progress on evaluation methods for skeletal muscle mass assessment in sarcopenia (Review).肌少症中骨骼肌质量评估方法的研究进展(综述)
Oncol Lett. 2025 Jul 3;30(3):423. doi: 10.3892/ol.2025.15169. eCollection 2025 Sep.
2
Possible Use of Body Surface Area Value for Estimating Skeletal Muscle Mass in Chronic Liver Disease.体表面积值在慢性肝病骨骼肌质量估计中的可能应用
Diagnostics (Basel). 2025 Jan 23;15(3):263. doi: 10.3390/diagnostics15030263.
3
The finger-ring test as an indicator of muscle mass estimated by dual-energy X-ray absorptiometry in an adult community-dwelling population.

本文引用的文献

1
Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease.肌脂肪变性对慢性肝病患者骨骼肌体积丢失的影响。
J Gastroenterol Hepatol. 2018 Feb 27. doi: 10.1111/jgh.14133.
2
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.接受肝癌切除术的患者肌肉量和肌肉功能下降的影响。
J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19.
3
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.
指环试验作为成人社区居住人群中通过双能X线吸收法估算肌肉量的指标。
Eur J Clin Nutr. 2025 May;79(5):435-442. doi: 10.1038/s41430-024-01550-5. Epub 2024 Dec 4.
4
Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements.社区中用于肌肉减少症筛查的Yubi-Wakka测试:与小腿围测量的比较一致性、诊断性能和有效性
J Frailty Aging. 2024;13(2):98-107. doi: 10.14283/jfa.2024.25.
5
Simple method for predicting muscle volume loss using geriatric nutritional risk index in hepatocellular carcinoma patients.利用老年营养风险指数预测肝细胞癌患者肌肉量丢失的简单方法。
J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1906-1911. doi: 10.1002/jcsm.13268. Epub 2023 May 19.
6
Screening Tools for Sarcopenia.肌少症筛查工具。
In Vivo. 2021 Nov-Dec;35(6):3001-3009. doi: 10.21873/invivo.12595.
7
Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan.SARC-F问卷在慢性肝病患者肌肉减少症筛查中的应用:日本一项多中心横断面研究
J Clin Med. 2021 Aug 3;10(15):3448. doi: 10.3390/jcm10153448.
8
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.2020 年肝硬化循证临床实践指南。
J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7.
9
Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.握力与小腿围度联合作为肝病患者的有效预后评估系统:一项大型队列研究
Ann Transl Med. 2021 Apr;9(8):624. doi: 10.21037/atm-20-6901.
10
Sarcopenia and Frailty in Liver Cirrhosis.肝硬化中的肌肉减少症和衰弱症
Life (Basel). 2021 Apr 27;11(5):399. doi: 10.3390/life11050399.
《恶病质、肌肉减少症与肌肉杂志》发表伦理准则:2017 年更新版
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083. doi: 10.1002/jcsm.12261. Epub 2017 Nov 3.
4
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.补充支链氨基酸及步行锻炼对预防肝硬化患者肌肉减少症的疗效
Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1416-1423. doi: 10.1097/MEG.0000000000000986.
5
Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension.肌肉量减少是肝硬化患者死亡的一个预后因素,且与门静脉高压存在特殊关系。
Hepatol Res. 2018 Feb;48(3):E354-E359. doi: 10.1111/hepr.12984. Epub 2017 Oct 18.
6
"Yubi-wakka" (finger-ring) test: A practical self-screening method for sarcopenia, and a predictor of disability and mortality among Japanese community-dwelling older adults.“指环”试验:肌少症的一种实用自我筛查方法,可预测日本社区居住老年人的残疾和死亡风险。
Geriatr Gerontol Int. 2018 Feb;18(2):224-232. doi: 10.1111/ggi.13163. Epub 2017 Sep 12.
7
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.日本肝脏学会肝病相关肌少症指南(第 1 版):肌少症评估标准制定工作组的推荐意见。
Hepatol Res. 2016 Sep;46(10):951-63. doi: 10.1111/hepr.12774.
8
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib.肌肉体积减少作为索拉非尼治疗的肝细胞癌患者的预后标志物
Hepatol Res. 2017 May;47(6):558-565. doi: 10.1111/hepr.12780. Epub 2016 Aug 30.
9
Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease.日本慢性肝病患者的肌肉减少症及两种类型的肌肉减少症前期状态
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):940-7. doi: 10.1097/MEG.0000000000000661.
10
Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma.肌肉减少症是70岁及以上肝细胞癌患者肝切除术后的不良预后因素。
Hepatol Res. 2016 Nov;46(12):1247-1255. doi: 10.1111/hepr.12674. Epub 2016 Apr 28.